|Potency||50 mg / ml|
|Appearance||water based Nano-Suspension|
|Indications||Stanozolol is indicated for treatment of Antianemic, Aplastic anemia, Angioedema and Antithrombin III deficiency.|
* Supplied in a clear 10 ml glass vials with plastic cap.
Notes on temperatures the properties:
At cold storage below 0°C temperatures the properties of this water-based nano-suspension might temporarily change (e.g. higher viscosity, cloudiness). If stored at cold temperature, the product should be brought to room or body temperature before use. The suspension for intramuscular injection is to be visually inspected prior to use and only clear solutions free from particles should be used.
Notes on handling the vial:
The vial is for single or multi-use. The content of a vial is to be injected intramuscularly after drawing up into the syringe and warming up. After removal of the plastic cap (A) do not remove the metal ring (B) or the crimp cap (C).
Store at room temperature, 10° – 24°C.
Avoid freezing. and cool temperatures below 10°C.
DO NOT FREEZE
When freezing and thawing cycles are repeated it will lead to an irreversible aggregation and with the result that the properties of the formulation may be drastically changed. If freezing occurs water can enlarge and even break the vial.
Stanozolol (abbrev. Stz), sold under many brand names, is an androgen and anabolic steroid (AAS) medication which was derived from dihydrotestosterone (DHT). It was developed by American pharmaceutical company Winthrop Laboratories (Sterling Drug) in 1962, and has been approved by the U.S. Food and Drug Administration for human use, though it is no longer marketed in the USA. It is also used in veterinary medicine. Stanozolol has mostly been discontinued, and remains available in only a few countries. It is given by mouth in humans or by injection into muscle in animals.
Unlike most injectable AAS, stanozolol is not esterified and is sold as an aqueous suspension, or in oral tablet form. The drug has a high oral bioavailability, due to a C17α alkylation which allows the hormone to survive first-pass liver metabolism when ingested. It is because of this that stanozolol is also sold in tablet form.
Stanozolol is one of the AAS commonly used as performance-enhancing drugs and is banned from use in sports competition under the auspices of the International Association of Athletics Federations (IAAF) and many other sporting bodies. Additionally, stanozolol has been used in US horse racing.
Stanozolol has been used with some success in treated venous insufficiency. It stimulates blood fibrinolysis and has been evaluated for the treatment of the more advanced skin changes in venous disease such as lipodermatosclerosis. Several randomized trials noted improvement in the area of lipodermatosclerosis, reduced skin thickness, and possibly faster ulcer healing rates with stanozolol. It has also been used to successfully treat hereditary angioedema.
Information contained within this website is not a prescription to use and is intended for information purposes only. Our products are made in Europe area and follow local laws accordingly, but FOR EXPORT ONLY. All manufacturing is in accordance with USP or BP Guidelines. Please Note: We are not an online store. We do not sell or ship to the USA, Europe, Australia or any other locations where prohibited. All information contained within this website or in any literature provided is not a prescription to use. Please seek the advise of a physician specializing in Andrology before use.